Solvemed | AI Pupillometry System

Solvemed Group is a Neuroscience AI company working to redefine neurological care. Founded in 2019 and based in the United States, Solvemed has recently secured a significant £3.20M in Seed Round investment on 05 October 2022. The investment was led by Apex Ventures, Atmos Ventures, Preface Ventures, Sunfish Partners, Techni Ventures, and Tensor Ventures, showcasing strong support from prominent VC firms. Solvemed's proprietary machine learning technology is at the forefront of developing digital pupillometry and eye movement clinical examination and remote monitoring tools, with a primary focus on critical care. These innovative products hold the potential to revolutionize patient care and treatment outcomes while also streamlining clinical pathways and workflows in healthcare systems. With its compelling vision and strong backing, Solvemed is poised to make a significant impact in the intersection of AI and neurology.